Skip to content

INTUIT Hip Fracture Outcome Study

Intramedullary Nailing for Treatment of Unstable InterTrochanteric (INTUIT) Hip Fracture Outcome Study.

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00595634
Acronym
INTUIT
Enrollment
92
Registered
2008-01-16
Start date
2008-01-31
Completion date
2013-11-30
Last updated
2014-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable Intertrochanteric Hip Fractures

Keywords

Hip, Fracture, Intertrochanteric, intramedullary

Brief summary

The primary objective of this study is to characterize patients' course of recovery in the year following the initial surgery for unstable intertrochanteric hip fractures treated with the InterTAN intramedullary hip screw device. This will be done by collecting patient outcome measures of health related quality of life and functional status including return to normal gait. Secondary objectives are to document any adverse events associated with the procedure, and to analyze differences in recovery due to differences in age, gender, co-morbidities, nutrition, residence and ambulation status, and use of mobility aids.

Interventions

None listed

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unilateral unstable intertrochanteric hip fracture without other lower extremity fractures. * Community and household ambulators with or without assistive devices. * Age 50 years or greater.

Exclusion criteria

* Stable intertrochanteric hip fracture. * Bilateral or two or more lower extremity fractures. * Non-functional ambulators or non-ambulators. * Age less than 50 years.

Design outcomes

Primary

MeasureTime frame
Mobility function as defined by the Timed Up & Go (TUG) frequency.Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months

Secondary

MeasureTime frame
Lower Extremity Activity ScaleBaseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months
EuroQolBaseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months
Visual Analogue Score (VAS)Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months
Adverse EventWhen necessary

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026